Neuro42 Company
Neuro42 is developing and commercializing advanced MRI technology for diagnosis and image-guided interventions.
Funding Status:
Early Stage Venture
Headquarters:
Oakland, California, United States
Founded Date:
2020-01-01
Last Funding Type:
Series A
Total Funding:
7800000.0
Industry:
Neurodegenerative disease diagnosis and treatment
Investors Number:
4.0
Last Funding Date:
2021-07-27